Table 1.
Association of human papilloma virus with ocular surface squamous neoplasia
Study details | HPV positivity
|
||
---|---|---|---|
Intraepithelial neoplasia | Invasive carcinoma | Control | |
HPV was tested by PCR in 418 patients from Uganda. The risk of OSSN was increased with multiple HPV genotype infection (OR 18.3; 95% CI 6.2–54.4) versus single HPV genotype infection (OR 2.3; 95% CI 1.2–4.4). HPV 5 and 8 were the most common serotypes detected [24•] | 41% cutaneous HPV* | 45% cutaneous HPV* | 11% cutaneous HPV* |
Ten consecutive patients with conjunctival intraepithelial neoplasia in the United States [25] | 100% (50% HPV 16 and 50% HPV 18) | NA | NA |
Thirty-eight HIV-infected patients with OSSN from Kenya and Uganda tested for HPV by PCR [26•] | 61% HPV 18 and 16% double genotype HPV 16 + 18 | ||
Fourteen conjunctival carcinoma samples at autopsy tested for HPV by highly sensitive nonradioactive in-situ hybridization technique in a study from Tanzania [27] | 93% HPV 18, 86% HPV 16 and HPV 6/11 | ||
Thirty-two patients with OSSN from Germany tested for HPV by PCR [29•] | 0% | ||
Report of 60 patients from Uganda with conjunctival carcinoma, compared to 1214 controls tested for anti-HPV 16, 18 and 45 antibodies. The presence of anti-HPV-16 antibodies was not significantly associated with OSSN (OR 1.5; 95% CI 0.5–4.3; P = 0.5) [30] | NA | 21% HPV 16. 10% HPV 18 and 5% HPV 45 | 10% HPV 16, 4% HPV 18 and 6% HPV 45 |
CI, confidence interval; HPV, human papilloma virus; OR, odds ratio; OSSN, ocular surface squamous neoplasia.